Cargando…

Best evidence topic: Should patients with asymptomatic choledocholithiasis be treated differently from those with symptomatic or complicated disease?

Choledocholithiasis is a common finding in clinical practice, with presentation varying from asymptomatic to life-threatening complications. In symptomatic patients, there is no doubt that treatment to clear the bile duct is indicated, but there is still a debate regarding the treatment of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Nawara, Hossam, Ibrahim, Rashid, Abounozha, Sabry, Alawad, Awad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820301/
https://www.ncbi.nlm.nih.gov/pubmed/33520213
http://dx.doi.org/10.1016/j.amsu.2020.12.048
_version_ 1783639180937527296
author Nawara, Hossam
Ibrahim, Rashid
Abounozha, Sabry
Alawad, Awad
author_facet Nawara, Hossam
Ibrahim, Rashid
Abounozha, Sabry
Alawad, Awad
author_sort Nawara, Hossam
collection PubMed
description Choledocholithiasis is a common finding in clinical practice, with presentation varying from asymptomatic to life-threatening complications. In symptomatic patients, there is no doubt that treatment to clear the bile duct is indicated, but there is still a debate regarding the treatment of patients with silent common bile duct stones (CBDS). The question addressed by this best evidence topic is whether patients with asymptomatic CBDS should be managed in the same way as patients with symptoms or complications. The search strategy yielded 609 articles, from which 8 articles found to be relevant to this topic. We also summarised the most notable societal guidelines recommendations, regarding this topic. We tabulated the article title, author, year, country, study type, outcomes, results, and comments. We concluded that patients with asymptomatic CBD stones should be offered endoscopic treatment If they are fit, after discussion of the potential risks and benefits of both options of conservative and interventional treatment with the patients.
format Online
Article
Text
id pubmed-7820301
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-78203012021-01-29 Best evidence topic: Should patients with asymptomatic choledocholithiasis be treated differently from those with symptomatic or complicated disease? Nawara, Hossam Ibrahim, Rashid Abounozha, Sabry Alawad, Awad Ann Med Surg (Lond) Best Evidence Topic Choledocholithiasis is a common finding in clinical practice, with presentation varying from asymptomatic to life-threatening complications. In symptomatic patients, there is no doubt that treatment to clear the bile duct is indicated, but there is still a debate regarding the treatment of patients with silent common bile duct stones (CBDS). The question addressed by this best evidence topic is whether patients with asymptomatic CBDS should be managed in the same way as patients with symptoms or complications. The search strategy yielded 609 articles, from which 8 articles found to be relevant to this topic. We also summarised the most notable societal guidelines recommendations, regarding this topic. We tabulated the article title, author, year, country, study type, outcomes, results, and comments. We concluded that patients with asymptomatic CBD stones should be offered endoscopic treatment If they are fit, after discussion of the potential risks and benefits of both options of conservative and interventional treatment with the patients. Elsevier 2021-01-13 /pmc/articles/PMC7820301/ /pubmed/33520213 http://dx.doi.org/10.1016/j.amsu.2020.12.048 Text en © 2021 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Best Evidence Topic
Nawara, Hossam
Ibrahim, Rashid
Abounozha, Sabry
Alawad, Awad
Best evidence topic: Should patients with asymptomatic choledocholithiasis be treated differently from those with symptomatic or complicated disease?
title Best evidence topic: Should patients with asymptomatic choledocholithiasis be treated differently from those with symptomatic or complicated disease?
title_full Best evidence topic: Should patients with asymptomatic choledocholithiasis be treated differently from those with symptomatic or complicated disease?
title_fullStr Best evidence topic: Should patients with asymptomatic choledocholithiasis be treated differently from those with symptomatic or complicated disease?
title_full_unstemmed Best evidence topic: Should patients with asymptomatic choledocholithiasis be treated differently from those with symptomatic or complicated disease?
title_short Best evidence topic: Should patients with asymptomatic choledocholithiasis be treated differently from those with symptomatic or complicated disease?
title_sort best evidence topic: should patients with asymptomatic choledocholithiasis be treated differently from those with symptomatic or complicated disease?
topic Best Evidence Topic
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820301/
https://www.ncbi.nlm.nih.gov/pubmed/33520213
http://dx.doi.org/10.1016/j.amsu.2020.12.048
work_keys_str_mv AT nawarahossam bestevidencetopicshouldpatientswithasymptomaticcholedocholithiasisbetreateddifferentlyfromthosewithsymptomaticorcomplicateddisease
AT ibrahimrashid bestevidencetopicshouldpatientswithasymptomaticcholedocholithiasisbetreateddifferentlyfromthosewithsymptomaticorcomplicateddisease
AT abounozhasabry bestevidencetopicshouldpatientswithasymptomaticcholedocholithiasisbetreateddifferentlyfromthosewithsymptomaticorcomplicateddisease
AT alawadawad bestevidencetopicshouldpatientswithasymptomaticcholedocholithiasisbetreateddifferentlyfromthosewithsymptomaticorcomplicateddisease